[Platelet reactions and immune processes. V. Inhibition by substrates and chymotrypsin inhibitors of ADP liberation by platelets].
D000227:Adenine Nucleotides / Q000032:analysis / Q000378:metabolism*; D001792:Blood Platelets / Q000187:drug effects / Q000276:immunology*; D002918:Chymotrypsin / Q000037:antagonists & inhibitors*; D002934:Cinnamates / Q000494:pharmacology; D003094:Collagen / Q000494:pharmacology*; D004952:Esters; D006801:Humans; D007546:Isoquinolines / Q000494:pharmacology; D008407:Mast Cells / Q000187:drug effects; D010636:Phenols / Q000494:pharmacology; D010649:Phenylalanine / Q000494:pharmacology; D010653:Phenylbutazone; D010973:Platelet Adhesiveness / Q000187:drug effects; D014364:Tryptophan / Q000494:pharmacology
D000227:Adenine Nucleotides; D002934:Cinnamates; D004952:Esters; D007546:Isoquinolines; D010636:Phenols; D010649:Phenylalanine; D014364:Tryptophan; D003094:Collagen; D002918:Chymotrypsin; D010653:Phenylbutazone
Réactions plaquettaires et processes immunitaires. V. Inhibition par des substrats et inhibiteurs de la chymotrypsine de la libération d'ADP par les plaquettes.